U S PHYSICAL THERAPY INC /NV (USPH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 80M 160M 240M Q3 '16: 88.3M Q4 '16: 90.9M Q1 '17: 97.6M Q2 '17: 104.3M Q3 '17: 103M Q4 '17: 109.2M Q1 '18: 108.3M Q2 '18: 115.1M Q3 '18: 113.1M Q4 '18: 117.3M Q1 '19: 116.2M Q2 '19: 126.4M Q3 '19: 117.3M Q4 '19: 122.1M Q1 '20: 112.7M Q2 '20: 83.9M Q3 '20: 108.9M Q4 '20: 117.5M Q1 '21: 112.4M Q2 '21: 126.9M Q3 '21: 125.9M Q4 '21: 129.8M Q1 '22: 131.7M Q2 '22: 140.7M Q3 '22: 139.6M Q4 '22: 141.2M Q1 '23: 148.5M Q2 '23: 151.5M Q3 '23: 150M Q4 '23: 154.8M Q1 '24: 155.7M Q2 '24: 167.2M Q3 '24: 168M Q4 '24: 180.4M Q1 '25: 183.8M Q2 '25: 197.3M Q3 '25: 197.1M Q4 '25: 202.7M Q1 '26: 198.3M Q2 '26: 214.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

0 15M 30M 45M Q3 '16: 19.7M Q4 '16: 18.8M Q1 '17: 20.7M Q2 '17: 24.5M Q3 '17: 21.2M Q4 '17: 24.1M Q1 '18: 23.2M Q2 '18: 27.2M Q3 '18: 26.1M Q4 '18: 25.2M Q1 '19: 26.7M Q2 '19: 31.4M Q3 '19: 27.4M Q4 '19: 27M Q1 '20: 15.7M Q2 '20: 19.3M Q3 '20: 30.4M Q4 '20: 29.1M Q1 '21: 25.9M Q2 '21: 34.3M Q3 '21: 29.8M Q4 '21: 27.2M Q1 '22: 26.6M Q2 '22: 30.8M Q3 '22: 26.8M Q4 '22: 27.8M Q1 '23: 30.9M Q2 '23: 32.2M Q3 '23: 27.9M Q4 '23: 30.5M Q1 '24: 28.4M Q2 '24: 33.9M Q3 '24: 29.1M Q4 '24: 32.5M Q1 '25: 31.1M Q2 '25: 41.6M Q3 '25: 36.9M Q4 '25: 40.1M Q1 '26: 32.8M Q2 '26: 41.9M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income Quarterly

-9M 0 9M 18M 27M Q3 '16: 12.1M Q4 '16: 11M Q1 '17: 12.2M Q2 '17: 15.7M Q3 '17: 12.9M Q4 '17: 14M Q1 '18: 13.1M Q2 '18: 17M Q3 '18: 15.4M Q4 '18: 14.8M Q1 '19: 15.4M Q2 '19: 19.9M Q3 '19: 16.8M Q4 '19: 15.3M Q1 '20: 4M Q2 '20: 10.3M Q3 '20: 19.9M Q4 '20: 18.2M Q1 '21: 15M Q2 '21: 22.2M Q3 '21: 16.9M Q4 '21: 16.5M Q1 '22: 15M Q2 '22: 20.1M Q3 '22: 14.9M Q4 '22: 6.8M Q1 '23: 17M Q2 '23: 20.1M Q3 '23: 15.9M Q4 '23: -2.4M Q1 '24: 14.9M Q2 '24: 15.6M Q3 '24: 12.8M Q4 '24: 19.7M Q1 '25: 19.6M Q2 '25: 24.9M Q3 '25: 25.3M Q4 '25: 16.8M Q1 '26: 12.5M Q2 '26: 21.9M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

0 5M 10M 15M Q3 '16: 4.8M Q4 '16: 5.2M Q1 '17: 4.8M Q2 '17: 4.9M Q3 '17: 5.2M Q4 '17: 7.3M Q1 '18: 7.1M Q2 '18: 9.2M Q3 '18: 8.1M Q4 '18: 10.4M Q1 '19: 8.4M Q2 '19: 14.6M Q3 '19: 9M Q4 '19: 7.9M Q1 '20: 1M Q2 '20: 10.2M Q3 '20: 10.9M Q4 '20: 13M Q1 '21: 8.2M Q2 '21: 12.4M Q3 '21: 10M Q4 '21: 10.2M Q1 '22: 8.8M Q2 '22: 11.2M Q3 '22: 9.6M Q4 '22: 2.6M Q1 '23: 7.4M Q2 '23: 10.9M Q3 '23: 9.3M Q4 '23: 656K Q1 '24: 8M Q2 '24: 7.5M Q3 '24: 6.6M Q4 '24: 9.2M Q1 '25: 9.9M Q2 '25: 12.4M Q3 '25: 13.1M Q4 '25: 4.2M Q1 '26: 5M Q2 '26: 9.9M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 60M 120M 180M Q3 '16: 68.7M Q4 '16: 72.1M Q1 '17: 76.8M Q2 '17: 79.7M Q3 '17: 81.8M Q4 '17: 85.1M Q1 '18: 85.1M Q2 '18: 87.9M Q3 '18: 87M Q4 '18: 92.1M Q1 '19: 89.5M Q2 '19: 94.9M Q3 '19: 89.9M Q4 '19: 95.2M Q1 '20: 97M Q2 '20: 64.6M Q3 '20: 78.6M Q4 '20: 88.3M Q1 '21: 86.5M Q2 '21: 92.6M Q3 '21: 96.1M Q4 '21: 102.7M Q1 '22: 105.1M Q2 '22: 109.8M Q3 '22: 112.8M Q4 '22: 113.4M Q1 '23: 117.7M Q2 '23: 119.3M Q3 '23: 122.1M Q4 '23: 124.3M Q1 '24: 127.3M Q2 '24: 133.3M Q3 '24: 138.9M Q4 '24: 147.9M Q1 '25: 152.7M Q2 '25: 155.7M Q3 '25: 160.3M Q4 '25: 162.6M Q1 '26: 165.5M Q2 '26: 172.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-15M 0 15M 30M 45M Q3 '16: 7.9M Q4 '16: 12.1M Q1 '17: 14.2M Q2 '17: 8M Q3 '17: 18.6M Q4 '17: 15.7M Q1 '18: 15.5M Q2 '18: 15.1M Q3 '18: 23.4M Q4 '18: 19M Q1 '19: 13.6M Q2 '19: 15.1M Q3 '19: 17.8M Q4 '19: 16M Q1 '20: 16.4M Q2 '20: 32M Q3 '20: 26.2M Q4 '20: 25.4M Q1 '21: 17.7M Q2 '21: 17.9M Q3 '21: 24.9M Q4 '21: 15.9M Q1 '22: 11.6M Q2 '22: 15.9M Q3 '22: 13.7M Q4 '22: 17.3M Q1 '23: 11.3M Q2 '23: 27.4M Q3 '23: 16.4M Q4 '23: 26.8M Q1 '24: 4.4M Q2 '24: 29M Q3 '24: 22.1M Q4 '24: 19.4M Q1 '25: -4.7M Q2 '25: 34.9M Q3 '25: 19.9M Q4 '25: 24.9M Q1 '26: 3.8M Q2 '26: 34.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-15M 0 15M 30M 45M Q3 '16: 5.8M Q4 '16: 9.4M Q1 '17: 12.6M Q2 '17: 6.4M Q3 '17: 16.3M Q4 '17: 14.2M Q1 '18: 14.1M Q2 '18: 13.2M Q3 '18: 21.3M Q4 '18: 17.1M Q1 '19: 11.1M Q2 '19: 12.7M Q3 '19: 15.3M Q4 '19: 13.2M Q1 '20: 13.6M Q2 '20: 30.1M Q3 '20: 25.4M Q4 '20: 23.2M Q1 '21: 16.1M Q2 '21: 16.2M Q3 '21: 22.2M Q4 '21: 13.7M Q1 '22: 9.1M Q2 '22: 13.8M Q3 '22: 11M Q4 '22: 16.3M Q1 '23: 9.3M Q2 '23: 25M Q3 '23: 13.8M Q4 '23: 24.6M Q1 '24: 2.6M Q2 '24: 26.7M Q3 '24: 19.6M Q4 '24: 16.9M Q1 '25: -7.3M Q2 '25: 31.6M Q3 '25: 15.6M Q4 '25: 21M Q1 '26: -1.6M Q2 '26: 29M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 6M 12M 18M Q3 '12: 11.9M Q4 '12: 12.1M Q1 '13: 12M Q2 '13: 12.1M Q3 '13: 12.1M Q4 '13: 12.1M Q1 '14: 12.1M Q2 '14: 12.2M Q3 '14: 12.2M Q4 '14: 12.3M Q1 '15: 12.3M Q2 '15: 12.4M Q3 '15: 12.4M Q4 '15: 12.4M Q1 '16: 12.4M Q2 '16: 12.5M Q3 '16: 12.5M Q1 '17: 12.5M Q2 '17: 12.6M Q3 '17: 12.6M Q1 '20: 12.8M Q2 '20: 12.8M Q3 '20: 12.8M Q1 '21: 12.9M Q2 '21: 12.9M Q3 '21: 12.9M Q1 '22: 12.9M Q2 '22: 13M Q3 '22: 13M Q1 '23: 13M Q2 '23: 13.7M Q3 '23: 15M Q1 '24: 15M Q2 '24: 15.1M Q3 '24: 15.1M Q1 '25: 15.1M Q2 '25: 15.2M Q3 '25: 15.2M Q1 '26: 15.2M Q2 '26: 15.1M Q3 '13 Q4 '14 Q1 '16 Q3 '17 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.50 3.00 4.50 Q4 '13: 1.06 Q1 '14: 1.02 Q2 '14: 1.13 Q3 '14: 1.54 Q4 '14: 1.63 Q1 '15: 1.70 Q2 '15: 1.66 Q3 '15: 1.70 Q4 '15: 1.77 Q1 '16: 1.86 Q2 '16: 1.95 Q3 '16: 1.94 Q4 '16: 1.88 Q1 '17: 1.83 Q2 '17: 1.65 Q3 '17: 1.60 Q4 '17: 1.75 Q1 '18: 1.64 Q2 '18: 1.73 Q3 '18: 1.45 Q4 '18: 1.31 Q1 '19: 1.43 Q2 '19: 1.80 Q3 '19: 2.33 Q4 '19: 2.45 Q1 '20: 2.26 Q2 '20: 2.40 Q3 '20: 2.35 Q4 '20: 2.48 Q1 '22: 2.87 Q2 '22: 2.92 Q3 '22: 2.98 Q4 '22: 2.24 Q1 '23: 2.15 Q2 '23: 1.92 Q3 '23: 1.71 Q4 '24: 1.84 Q1 '25: 2.18 Q2 '25: 2.29 Q3 '25: 2.38 Q4 '14 Q1 '16 Q2 '17 Q3 '18 Q4 '19 Q1 '22 Q2 '23 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.